Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

BioNTech SE (BNTX)

  • Event
  • Nov. 03, 2025, 11:50 UTC
  • 44
  • 1 comments

BioNTech SE (BNTX) Files Form 6-K

Comment Full text

BioNTech SE (BNTX)

  • Event
  • Nov. 03, 2025, 11:49 UTC
  • 36
  • 1 comments

BioNTech SE (BNTX) Files Form 6-K

Comment Full text

GSK plc (GLAXF)

  • Event
  • Nov. 03, 2025, 11:25 UTC
  • 37
  • 1 comments

GSK plc (GLAXF) Files Form 6-K

Comment Full text

Alvotech (ALVOW)

  • Event
  • Nov. 03, 2025, 11:11 UTC
  • 34
  • 1 comments

Alvotech (ALVOW) Files Form 6-K

Comment Full text

HUTCHMED DRC (HCM)

  • Event
  • Nov. 03, 2025, 11:03 UTC
  • 35
  • 1 comments

HUTCHMED DRC (HCM) Files Form 6-K

Comment Full text

Boston Scientific Corp (BSX)

  • Event
  • Oct. 27, 2025, 14:50 UTC
  • 31
  • 1 comments

📋 Zane Ellen M (Director) plans to sell 10K shares of BOSTON SCIENTIFIC CORP (at $100.91 each, total $1.0M) Filed: Oct 27, 2025 | ID: 000219

Comment Full text

Medpace Holdings Inc (MEDP)

  • Event
  • Oct. 27, 2025, 14:30 UTC
  • 32
  • 1 comments

📋 EWALD STEPHEN P (Officer) plans to sell 15K shares of Medpace Holdings, Inc. (at $598.85 each, total $9.1M) Filed: Oct 27, 2025 | ID: 006559

Comment Full text

Teva Pharmaceutical Industries Ltd. (TEVJF)

  • Event
  • Feb. 18, 2025, 17:38 UTC
  • 72
  • 1 comments

📋 Francis Richard D (Officer) plans to sell 76K shares of TEVA PHARMACEUTICAL INDUSTRIES LTD (at $16.95 each, total $1.3M) Filed: Feb 18, 2025 | ID: 000032

Comment Full text

Green Thumb Industries Inc. (GTBIF)

  • Event
  • Nov. 08, 2024, 00:00 UTC
  • 34
  • 1 comments

(32% Neutral) GREEN THUMB INDUSTRIES INC. (GTBIF) Reports 45% Profit Decline for 2024-09-30

Comment Full text

Glass House Brands Inc. (GLASF)

  • Event
  • May 22, 2024, 10:02 UTC
  • 42
  • 1 comments

(99% Neutral) Glass House Brands Inc. (GLASF) Files Form 6-K

Comment Full text
  • Previous
  • 477
  • 478
  • 479
  • 480
  • 481
  • Next

Search

News categories

  • Technical Exchange News(12448)
  • Event(6229)
  • SEC News(278889)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(160221)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin